InvestSMART

Amplia Therapeutics Limited (ASX: ATX) - Announcements

Current share price for ATX : $0.148 0.003 (1.72%)+

ASX company news and announcements for Amplia Therapeutics Limited (ATX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Amplia Therapeutics Limited (ATX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Amplia Therapeutics Limited (ATX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Amplia Therapeutics Limited (ATX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$74 Appendix 3B - Placement 24 Jan 2020 1:28PM $0.072 $0.145 risen by 101.39%
$74 Amplia Therapeutics Undertakes Placement 20 Jan 2020 9:42AM $0.080 $0.145 risen by 81.25%
$74 Trading Halt 16 Jan 2020 9:15AM $0.080 $0.145 risen by 81.25%
$74 Change of Registered Office and Principal Place of Business 18 Dec 2019 4:47PM $0.070 $0.145 risen by 107.14%
$74 Shareholder Update / 2019 Review 17 Dec 2019 10:01AM $0.070 $0.145 risen by 107.14%
$74 App 4D - Financial Report Half Year Ended 30 Sep 2019 29 Nov 2019 1:38PM $0.080 $0.145 risen by 81.25%
$74 App 4C - Sep 2019 Qtr Cash Flows Statement 1 Nov 2019 9:07AM $0.080 $0.145 risen by 81.25%
$74 Becoming a substantial holder 1 Nov 2019 8:13AM $0.080 $0.145 risen by 81.25%
$74 Ceasing to be a substantial holder 1 Nov 2019 8:13AM $0.080 $0.145 risen by 81.25%
$74 Change of Director's Interest - Dr Robert Peach - Placement 17 Sep 2019 2:58PM $0.080 $0.145 risen by 81.25%
$74 Change of Director's Interest - Dr C Behrenbruch - Placement 17 Sep 2019 2:57PM $0.080 $0.145 risen by 81.25%
$74 Change of Director's Interest - Dr Warwick Tong, Placement 17 Sep 2019 2:56PM $0.080 $0.145 risen by 81.25%
$74 Placement Cleansing Notice 17 Sep 2019 2:02PM $0.080 $0.145 risen by 81.25%
$74 App 3B Placement Shares and Options to Directors and Mgt 17 Sep 2019 1:54PM $0.080 $0.145 risen by 81.25%
$74 Amplia Therapeutics Provides Manufacturing Update 2 Sep 2019 8:59AM $0.089 $0.145 risen by 62.92%
$74 Results of Annual General Meeting 30 Aug 2019 2:36PM $0.083 $0.145 risen by 74.70%
$74 Change of Director's Interest - S Wilkinson - Options Lapsed 21 Aug 2019 4:12PM $0.072 $0.145 risen by 101.39%
$74 Amplia Therapeutics - Quarterly Update 12 Aug 2019 8:23AM $0.091 $0.145 risen by 59.34%
$74 Change of Director's Interest - Dr Warwick Tong Rights Issue 5 Aug 2019 7:18PM $0.090 $0.145 risen by 61.11%
$74 Change of Director's Interest - Dr Chris Burns, Rights Issue 5 Aug 2019 7:15PM $0.090 $0.145 risen by 61.11%
$74 Change of Director's Interest - Andrew Cooke, Rights Issue 5 Aug 2019 7:14PM $0.090 $0.145 risen by 61.11%
$74 Appendix 4C - Quarterly Cash Flow Report - June 2019 Qtr 31 Jul 2019 5:32PM $0.125 $0.145 risen by 16%
$74 RightsIssue Participation Supports Clinical-Enabling Studies 31 Jul 2019 3:19PM $0.120 $0.145 risen by 20.83%
$74 Amplia Therapeutics - Bioshares Presentation July 2019 25 Jul 2019 4:36PM $0.120 $0.145 risen by 20.83%
$74 Appendix 4G - Key to Corporate Governance Disclosures 25 Jul 2019 4:35PM $0.120 $0.145 risen by 20.83%

451 - 475 of 528 results

Page 19 of 22

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.